SAN DIEGO--Privately held Structural Bioinformatics (SBI) elected Arne Gillin to its board of directors and named Dean Goddette vice-president of marketing and sales.
Gillin represented Dansk Kapitalanlaeg Aktieselskab in SBI's recent round of financing. Edward Maggio, SBI president and CEO, said Gillin will help move the company into a more global organization. "He'll assist us with our expansion in Europe, headquartered out of the Danish offices of SBI Advanced Technologies," Maggio commented.
Gillin has been with Dansk Kapitalanlaeg, the largest venture capital company in Denmark, for more than five years, and sits on the board of several biotech, high-tech, and software companies, including Acadia Pharmaceuticals.
With over 15 years experience in research, sales, and marketing, Goddette will assume primary responsibility for worldwide marketing strategies for SBI's structural database products and services. He also has a scientific background in protein engineering and x-ray crystallography. Maggio said Goddette's background "contains the exact mix of both technical and business expertise that SBI has been seeking for the upcoming release of our first protein-structure-based proteomics and pharmacogenomics database products." Goddette most recently served as a sales manager for Tripos's drug discovery product line. Prior to joining Tripos, he was director of life sciences at Molecular Simulations, where he managed the Quanta protein modeling product line.